MRK
Merck & Company Inc
148.80$
+0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.3% | +7.8% | +2.1% | +3.4% | -6.2% | 0.0% | +1.2% | +8.8% | -5.0% | -0.2% | +2.0% | – | |
| – | -8.3% | -9.5% | +5.8% | +8.9% | -6.2% | +1.5% | -1.0% | +9.0% | +14.9% | -38.9% | +49.3% | – | |
| – | -8.4% | +14.2% | +1.1% | +1.7% | -6.2% | -0.5% | +1.9% | +8.7% | -11.4% | +15.9% | -8.5% | – | |
| – | +191.1% | -58.5% | -12.3% | +67.5% | -21.8% | -32.0% | +13.5% | +0.3% | -29.6% | +402.5% | -22.4% | – | |
| – | -86.5% | +628.2% | +10.3% | -0.3% | -89.3% | +777.0% | +3.2% | +0.0% | +8.2% | -5.2% | +7.6% | – | |
| – | +113.4% | -19.4% | -37.7% | +37.7% | -13.3% | -32.5% | +11.3% | -1.2% | -3.2% | +184.8% | -15.3% | – | |
| – | -129.2% | – | +6.4% | -35.0% | +9.1% | +54.3% | -5.2% | +17.4% | -17.5% | -130.6% | – | – | |
| – | -2.2% | -2.3% | +2.3% | +6.5% | -0.6% | -4.6% | -2.6% | +7.2% | +25.7% | +16.5% | +9.6% | – | |
| – | -136.4% | – | +5.9% | -31.9% | +2.0% | +41.6% | -15.3% | +34.9% | -49.3% | -203.3% | – | – | |
| – | -194.3% | – | – | +70.5% | -54.1% | +92.0% | -30.2% | +67.8% | -52.2% | +54.8% | -7.8% | – | |
| – | -125.8% | – | +14.6% | -42.1% | +18.6% | +35.7% | -12.8% | +30.7% | -48.8% | -243.1% | – | – | |
| – | -111.1% | – | +10.4% | -24.7% | +1.6% | +28.4% | -13.1% | +28.1% | -22.7% | -132.1% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.